Coherus Oncology, Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Coherus Oncology, Inc. (CHRS) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $10.70 million as of 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-03-09
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $10.70M.
- 2024-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $24.60M.
- 2023-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $37.40M.
- 2022-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $51.50M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2025-12-31 | $10.70M 10-K · filed 2026-03-09 |
| 2024-12-31 | $24.60M 8-K · filed 2025-11-13 |
| 2023-12-31 | $37.40M 10-K · filed 2024-03-15 |
| 2022-12-31 | $51.50M 10-K · filed 2023-03-06 |
| 2021-12-31 | $61.40M 10-K · filed 2022-02-23 |
| 2020-12-31 | $68.50M 10-K · filed 2021-02-25 |
| 2019-12-31 | $56.40M 10-K · filed 2020-02-27 |
| 2018-12-31 | $49.70M 10-K · filed 2019-02-28 |
| 2017-12-31 | $51.90M 10-K · filed 2018-03-08 |
| 2016-12-31 | $68.90M 10-K · filed 2017-03-14 |
| 2015-12-31 | $55.20M 10-K · filed 2016-02-29 |
| 2014-12-31 | $18.50M 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |